Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam Kolev

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Swiss Medical Weekly|June 26, 2025
Active hepatitis B virus vaccination in the prevention of viral reactivation in liver transplantation recipients with previous hepatitis B infection: a cohort studyEric Adler, Yasemin Krucker, Mirjam Kolev, et al.
Praxis|February 7, 2013
[There is something amiss]Mirjam Kolev, Sarah Oppliger, Simon Jung, et al.
Journal of Translational Autoimmunity|March 21, 2022
Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchersMirjam Kolev, Michael P Horn, Nasser Semmo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 11, 2025
Exploring the Role of Thy-1 and Its Soluble Form Regarding Fibrosis Severity in Primary Biliary Cholangitis and Metabolic Dysfunction-Associated Fatty Liver DiseaseMirjam Kolev, Rahel Bütikofer, Anja Saalbach, et al.
Journal of Translational Autoimmunity|January 31, 2023
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case seriesMirjam Kolev, Adela-Cristina Sarbu, Burkhard Möller, et al.
Current Opinion in Immunology|May 25, 2025
Unmet needs in autoimmune liver diseasesMirjam Kolev, Andreas E Kremer, Christiane Sokollik, et al.
Journal of Translational Autoimmunity|December 1, 2022
Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysisMirjam Kolev, Stefan Diem, Lara Diem, et al.
Journal of Hepatology|February 27, 2007
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinomaDavid Semela, Anne-Christine Piguet, Mirjam Kolev, et al.
Swiss Medical Weekly|April 10, 2026
Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysisMirjam Kolev, Salomé Wolf, Elizabeth Petràš, et al.
Journal of Translational Autoimmunity|February 12, 2026
Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodiesMirjam Kolev, Michèle Freiburghaus, Guido Stirnimann, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Swiss Medical Weekly|June 26, 2025
Active hepatitis B virus vaccination in the prevention of viral reactivation in liver transplantation recipients with previous hepatitis B infection: a cohort studyEric Adler, Yasemin Krucker, Mirjam Kolev, et al.
Praxis|February 7, 2013
[There is something amiss]Mirjam Kolev, Sarah Oppliger, Simon Jung, et al.
Journal of Translational Autoimmunity|March 21, 2022
Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchersMirjam Kolev, Michael P Horn, Nasser Semmo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 11, 2025
Exploring the Role of Thy-1 and Its Soluble Form Regarding Fibrosis Severity in Primary Biliary Cholangitis and Metabolic Dysfunction-Associated Fatty Liver DiseaseMirjam Kolev, Rahel Bütikofer, Anja Saalbach, et al.
Journal of Translational Autoimmunity|January 31, 2023
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case seriesMirjam Kolev, Adela-Cristina Sarbu, Burkhard Möller, et al.
Current Opinion in Immunology|May 25, 2025
Unmet needs in autoimmune liver diseasesMirjam Kolev, Andreas E Kremer, Christiane Sokollik, et al.
Journal of Translational Autoimmunity|December 1, 2022
Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysisMirjam Kolev, Stefan Diem, Lara Diem, et al.
Journal of Hepatology|February 27, 2007
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinomaDavid Semela, Anne-Christine Piguet, Mirjam Kolev, et al.
Swiss Medical Weekly|April 10, 2026
Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysisMirjam Kolev, Salomé Wolf, Elizabeth Petràš, et al.
Journal of Translational Autoimmunity|February 12, 2026
Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodiesMirjam Kolev, Michèle Freiburghaus, Guido Stirnimann, et al.
Pageof 2